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Abstract
A novel cardiac-specific transgenic mouse model was generated to identify the physiological
consequences of elongated thin filaments during post-natal development in the heart.
Remarkably, increasing the expression levels in vivo of just one sarcomeric protein, Lmod2,
results in ~10% longer thin filaments (up to 26% longer in some individual sarcomeres) that
produce up to 50% less contractile force. Increasing the levels of Lmod2 in vivo (Lmod2-TG)
also allows us to probe the contribution of Lmod2 in the progression of cardiac myopathy
because Lmod2-TG mice present with a unique cardiomyopathy involving enlarged atrial
and ventricular lumens, increased heart mass, disorganized myofibrils and eventually, heart
failure. Turning off of Lmod2 transgene expression at postnatal day 3 successfully prevents
thin filament elongation, as well as gross morphological and functional disease progression.
We show here that Lmod2 has an essential role in regulating cardiac contractile force and
function.
Introduction
Contractile force in striated muscles is produced by the concerted interaction between inter-
digitating actin-based thin filaments and myosin-based thick filaments. As such, precise main-
tenance of filament lengths is essential for efficient contraction. Although it is known that
changes in thin filament lengths are linked to development of cardiac and skeletal myopathies
[1–5], how those changes contribute to the pathophysiological mechanism of disease progres-
sion has yet to be shown. Numerous actin-binding proteins have been shown to regulate the
lengths of actin filaments from their barbed ends in non-muscle cells; however, in mammalian
cardiac muscle cells, where dynamic regulation of thin filament lengths occurs from the
pointed ends in the center of the sarcomere, tropomodulin and leiomodin are the only pro-
teins reported to localize to the pointed ends, and function to maintain thin filament lengths
[reviewed in [6–8]].
Leiomodin (Lmod) and tropomodulin (Tmod) proteins are structurally similar to each
other, with Lmods containing a C-terminal extension with an extra actin-binding site [9–14].
Each of three leiomodin isoforms show a predominant expression pattern in different muscle
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[9,15–17]. Using a constitutive Lmod2-knockout mouse model, our laboratory demonstrated
that the absence of Lmod2 leads to rapid-onset dilated cardiomyopathy [4]; the observation
independently reached in a different study that investigated a transgenic mouse model with a
homozygous Lmod2-piggyBac mutation [18].
The first human mutation in Lmod2 (LMOD2, p.Trp398�) was only recently discovered;
this homozygous mutation resulted in undetectable Lmod2 protein expression, extremely
short thin filaments, and severe neonatal dilated cardiomyopathy [19]. As for other leiomodin
isoforms, a child with homozygous nonsense Lmod1 mutation died shortly after birth with a
rare condition called megacystis microcolon intestinal hypoperistalsis syndrome. Transgenic
mice with the same homozygous Lmod1 mutation are reported to have reduced assembly of
smooth-muscle actin and impaired intestinal smooth muscle contractility before they die
shortly after birth [20]. Loss-of-function Lmod3 human mutations present with severe congen-
ital nemaline myopathy and atrophic skeletal muscles comprised of shortened and disorga-
nized thin filaments [21–23].
In this study, to determine the consequences of longer thin filament length and how Lmod2
functions in cardiac muscle, we generated a novel transgenic mouse model (Lmod2-TG) that
overexpresses Lmod2 in a cardiac-specific manner. Because thin filaments are significantly
shorter in the absence of Lmod2 in hearts in vivo [4], we hypothesized that overexpression of
Lmod2 in vivo would result in an increase in cardiac thin filament length. Remarkably, we dis-
covered that thin filaments lengths in intact hearts in vivo can be manipulated by only altering
the levels of Lmod2; Lmod2-TG mice have ~10% longer thin filaments that produce drastically
reduced active contractile force. Lmod2-TG mice also exhibit a unique combination of pheno-
types associated with cardiomyopathies, such as enlarged atrial and ventricular lumens,
increased heart mass and myofibril disarray. Furthermore, functional defects observed in
Lmod2-TG hearts extend to both systolic (reduced percent ejection fraction) and diastolic
(reduced ventricular compliance) phases of the cardiac cycle. To our knowledge, this is the
first mammalian in vivo model that reveals the detailed consequences of longer thin filaments,
a phenomenon that ends in cardiac failure.
Materials and methods
Experimental samples were collected in order based on hand-markings randomly assigned at
birth. Genotype and gender information were blinded during experimental data acquisition.
Data gathered were from at least three biological replicates and at least two technical replicates.
Unless mentioned specifically, no statistically significant differences were observed between
males and females, and data reported (mean ± SEM) comes from an equal number of males
(M) and females (F) per genotype. Statistical analyses were carried out using two-tailed t-test
(for comparison between two samples), one-way ANOVA (for comparison between three or
more samples) or two-way ANOVA (for multiple comparisons) with recommended post-hoc
method/test (GraphPad Prism 8 for macOS; version 8.1.0 (221)). Data were considered signifi-
cant when post-hoc adjusted P values were less than 0.05.
Care and use of study animals
All animal procedures were approved by the Institutional Animal Care and Use Committee
(IACUC) at The University of Arizona. As required by our IACUC-approved animal protocol,
we used the minimum number of mice needed to obtain statistical significance (P<0.05)
based on power analysis. In addition, most of the physiological studies successfully carried out
in our Genetically Engineered Mouse Model (GEMM) core facility have used 6–8 animals of
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any given genotype per experiment. Hence, unless stated otherwise, most of our data were gen-
erated using 6 tissue samples per genotype per experiment (multiple tissue samples can be
extracted from one animal for various experimental types).
Health/status of all animals used were checked daily by laboratory animal room technician
(and veterinarian, as necessary). Study animals were handled in accordance with the Guiding
Principles in the Care and Use of Animals, approved by the Council of the American Physio-
logical Society, so that they will not experience distress, pain or suffering, any more than that
produced by routine handling. Briefly, before collection of experimental samples mice are
deeply anesthetized (as evident by a cessation of spontaneous movement and slowing of the
respiratory and heart rate) with isoflurane in an induction jar. Deeply anesthetized animals are
sacrificed by either rapid decapitation (if younger than P21, age to be weaned) or cervical dis-
location (P21 and older). Unused animals (or those found to be sick, injured, or otherwise
unusable as determined by the laboratory animals facility’s veterinarian) are euthanized by an
approved painless CO2 asphyxiation procedure. This procedure was chosen because it is rapid,
painless and in line with the recommendations of the Panel on Euthanasia of the American
Veterinary Medical Association.
Generation and maintenance of transgenic mice with cardiac-specific
leiomodin-2 overexpression
The coding sequence of full-length mouse leiomodin-2 (NM_053098.2; 1967-bp) was amplified
from cDNA generated from a neonatal mouse cardiomyocyte culture. Together with an N-ter-
minal c-Myc tag following a Kozak consensus [24], Lmod2 cDNA was cloned behind the
alpha-myosin heavy chain (alpha-MHC, Myh6) promoter [25] and a reversed floxxed tran-
scription termination sequence (so that exogenous Lmod2 expression can be turned off, as
needed) (S1A Fig). The transgenic colonies of two founder lines/clones were established by
crossing to a Black Swiss (BLSW) strain (Taconic through JAX) and maintained by crossing
Lmod2 transgene-positive (Lmod2-TG) males with littermate Lmod2 transgene-null (NTG)
females. No significant differences in Lmod2 protein expression levels, as well as cardiac thin
filament lengths were observed between the two founder lines. Presence of Lmod2 transgene
was confirmed at birth by PCR using genomic DNA. Primers used:
5'-GAGGAGGTGTGTACAGAAGATGAGGAAGAGTC (forward); and
5'-GGAGTTCCTCTGTGTTCTTCCACTGTTG (reverse).
Generation and administration of adeno-associated virus (AAV)
Adeno-associated viruses were generated using AAV Helper-Free System (Agilent Technolo-
gies). Plasmid DNA of pHelper, pAAV-RC, pAAV-cTNT-iCre-tdTomato (Cre; a gift from Dr.
William T. Pu (Boston Children’s Hospital), Addgene plasmid #69916) and pAAV-cTNT-
tdTomato (Tomato; control) were purified using a QIAGEN Plasmid Midi Kit. The purified
DNA of Helper and AAV-RC plus either Cre or Tomato were then mixed in a 1:1:1 molar
ratio. AAV-293 cells were transiently transfected with each DNA mixture (Cre or Tomato)
diluted in polyethylene-imine [1 mg/mL] (Polysciences, Inc.) in a 1:4 (weight-to-volume)
ratio. Twenty 15-cm culture dishes (per virus titer preparation) of AAV-293 cells at 60% con-
fluence were used. Cells were collected 72-hour post-transfection, and lysed via four freeze-
thaw cycles and an endonuclease treatment using 0.02% (vol/vol) Benzonase Nuclease (Sigma)
for an hour at 37˚C. Virus particles of Cre and Tomato (AAV_Cre and AAV_Tomato, respec-
tively) were purified and concentrated by passing crude lysates through an Iodixanol density
gradient (OptiPrep; Sigma) during centrifugation at 48,000 rpm for 2 hours at 18˚C. Purified
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virus titers were tested for vector genome-containing particles via quantitative PCR and stored
at -80˚C before use.
To turn transgenic expression of Lmod2 off AAV_Cre was injected into the intrapericardial
space of neonatal Lmod2-TG pups as described [26]. Briefly, approximately 2.5x1011-12 geno-
mic copies of AAV_Cre mixed in 50 μL of saline solution were injected into the intrapericar-
dial space of postnatal day 3 (P3) Lmod2-TG pups. NTG and Lmod2-TG littermates injected
with the similar amount AAV_Tomato served as experimental controls. The injected pups
were left to recover on the heating pad, set at 30˚C, for about 30 min before transferring back
into the cage.
Cardiac fiber mechanics (Force-Calcium relationship)
To determine the Force-Calcium relationship, as a function of diastolic sarcomere length, a
modified protocol of [27] was used. The compositions of all solutions were reported previously
[28]. Activating solution and relaxing solution were mixed accordingly to obtain activating
solution with a free Ca2+ range of 46.8–0.64 μmol/L. All experiments were performed at 15˚C,
unless otherwise mentioned.
The excised hearts from P15 and P60 mice were perfused retrograde with a modified
Krebs-Henseleit solution (pH 7.4; 118.5 mmol/L NaCl, 26.4 mmol/L NaHCO3, 2 mmol/L
NaH2PO4, 15 mmol/L KCl, 1.2 mmol/L MgSO4, 10 mmol/L glucose). Single unbranched fibers
along the ventricular wall were then dissected and permeabilized in standard relaxing solution
with 1% (vol/vol) Triton X-100 for ~4 hours at 4˚C. The skinned fiber was transferred into a
dish containing fresh relaxing solution (without Triton) and attached to an aluminum T-clip
and mounted on hooks between a transducer (Model AE801; Sensonor) and a high-speed
length controller (Model 322; Aurora Scientific). Measurements were taken at sarcomere
lengths of 1.95/2.10 ± 0.03 μm using the first order diffraction band from a He-Ne laser [29].
Before acquiring Force-Calcium measurements, each fiber was stretched to a sarcomere
length (SL) of 2.20–2.25 microns and a maximal activation of the fiber was performed to elimi-
nate end-compliance from the clipping process. After the “clip-setting” activation, SL was set
to 2.25 microns, and the passive tension was allowed to plateau, then a step-release was per-
formed to obtain the passive tension measurement. This process was repeated at SL of 2.15
and 2.05 microns, as well as at 2.10 and 1.95 microns (experimental SL), to build a passive ten-
sion curve.
For the Force-Calcium curve the relaxing solution that the fiber was incubated in was
briefly (3–4 min) exchanged with pre-activating solution before establishing the steady-state
force using activating solution with varying free Ca2+ concentrations (46.8–0.64 μmol/L). The
fiber was then slackened (to 25% of starting fiber length) to get peak force- and zero force-level
measurements. While the fiber is slack, the activating solution is replaced with relaxing solu-
tion, and then the fiber is re-stretched to the starting SL. This procedure was repeated for a
total of 9 activations to build the Force-Calcium relationship curve for each individual fiber. If
the final maximal activation for a particular SL was less than 85% of the initial maximal activa-
tion, the fiber was rejected from further analysis. Force-Calcium relationship curves were fit
individually to a modified Hill equation as previously described [28,30]: Frelative = [Ca
2+]n /
(EC50
n + [Ca2+]n), where Frelative = Force as a fraction of maximum force at saturating [Ca
2+]
(Fmax), and EC50 = [Ca
2+] where the Frelative is half of Fmax, and n = Hill Coefficient.
Cardiac functional assays
Echocardiography. Transthoracic echocardiographs were collected on a Vevo 3100 Ultra
High-Frequency Imaging Platform (FUJIFILM VisualSonics), and analyzed using AutoLV
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Analysis and VevoStrain software (Vevo LAB 1.7.0). Acquisition and analysis of echocardio-
graphs were performed according to American Society of Echocardiography guidelines. M-
mode acquisitions at the papillary muscle-level were used to examine ventricular function dur-
ing systole, and Pulse-wave and Tissue Doppler acquisitions were used to monitor cardiac con-
ditions during diastole. Echocardiographs of mice at both conscious and anesthetized
conditions were analyzed.
Pressure-Volume (PV) loop. PV-loop studies on P60 mice were conducted using a Sci-
sense Admittance Derived Volume (ADV500) measurement system and 1.2 F catheters with
4.5 mm electrode spacing (Transonic Scisense Inc.). Mice were anesthetized and ventilated
with 1–3% isoflurane using an SAR-1000 Ventilator (CWE Inc.). Body temperature was main-
tained at 37˚C using a MouseMonitor S platform (Indus Instruments). Mice were secured and
the abdomen was opened below the sternum. The apex of the left ventricle (LV) was punctured
using a 28-gauge needle and the catheter was advanced into the LV. Baseline PV-loop readings
were recorded during the steady state ~10 min after inserting the conductance catheter into
the LV apex. The IVC was located and occluded during a sigh (pause) in ventilation to acquire
load-independent indexes. Data acquisition and analysis was performed in LabScribe2
(iWorx). Pressure-Volume relationship data was analyzed using a mono-exponential fit (P = A
e βv+c) with the exponent (β) reported as the stiffness.
Histology
Hearts were excised, dissected in half (in longitudinal and transverse sections) in PBS, fixed in
10% neutral-buffered formalin (Sigma) overnight, dehydrated, and embedded in paraffin.
Ten-micron sections were stained using a Trichrome Stain (Masson) Kit (Sigma), and Picro-
sirius Red Stain Kit (Polysciences Inc.) according to manufacturers’ protocols. Bright-field
images were captured on a Zeiss Axio Imager M1 upright microscope using a Zeiss AxioCam
MRc5 camera and processed linearly using ImageJ (NIH) and Photoshop CC (Adobe)
software.
Immuno-assays
Immunoblotting. Sections of LV free wall (10–30 mg) in a microcentrifuge tube contain-
ing 300.μL of lysis buffer (pH 7.4; 150 mmol/L NaCl, 1.5 mmol/L MgCl2, 1 mmol/L EGTA, 10
mmol/L sodium pyrophosphate, 10 mmol/L sodium fluoride, 0.1 mmol/L sodium deoxycho-
late, 25 mmol/L HEPES, 1% Triton X-100, 1% SDS, 10% (vol/vol) glycerol, 1x protease inhibi-
tors cocktail) were homogenized using a Bullet Blender (BBX24; Next Advance) at setting 10
for 4 min at 4˚C. After spinning the crude lysate down at 16,000 x g for 15 min at 4˚C, the con-
centration of total protein extracted (supernatant) was normalized using a Pierce BCA Protein
Assay Kit (Thermo Fisher Scientific).
For soluble and insoluble fractionation experiments, all steps were carried out on ice using
ice-cold buffer solutions, and all centrifugation steps were carried out at 2,000 x g for 2 min at
4˚C. Briefly, fresh LV tissue sections were minced in Ringer buffer (pH 7.4; 150 mmol/L NaCl,
2 mmol/L KCl, 2 mmol/L MgCl2, 10 mmol/L KH2PO4, 1 mmol/L EGTA, 0.1% Glucose), and
thoroughly homogenized in Rigor buffer (pH 7.4; 100 mmol/L KCl, 2 mmol/L MgCl2, 10
mmol/L KH2PO4, 1 mmol/L EDTA, 1% Triton X-100, 1x Protease inhibitors cocktail) using a
tissue homogenizer (speed 3; 30-second interval up to 1.5 min). The supernatant after centrifu-
gation was collected as a soluble fraction and the pellet was further washed four times with
Rigor buffer (1x with and 3x without 1% Triton X-100). The washed pellet was then re-sus-
pended in lysis buffer, sonicated (setting 2; 30 sec intervals up to 1 min) and spun down.
Supernatant was then collected as an insoluble fraction, and concentration of extracted
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proteins in both soluble and insoluble fractions were normalized using a Pierce BCA Protein
Assay Kit.
Immunoblot samples were prepared in Laemmli Sample Buffer, resolved using a 4–15%
gradient SDS polyacrylamide gel (Bio-Rad), and transferred onto a Protran nitrocellulose
membrane (0.2-μm; GE Healthcare). The membrane was then stained with Ponceau S solu-
tion, and total density of each lane was quantified to normalize the amount of protein loaded.
Before incubating in primary antibodies overnight at 4˚C, the membrane was blocked with
10% (wt/vol) milk in TBST (pH 7.4; 19 mmol/L Tris, 2.7 mmol/L KCl, 137 mmol/L NaCl,
0.1% Tween-20) for 2–4 hours at room temperature. The membrane was washed thoroughly
with TBST before incubating in secondary antibodies for 2 hours at room temperature in the
dark. After the immunoblots were thoroughly washed with TBST, they were scanned and ana-
lyzed using an Odyssey CLx Imaging System and Image Studio Software (Li-COR).
Immunofluorescence and thin filament length measurements. LV tissues were dis-
sected into ~4.5x1.5 mm2 (length x width) pieces and stretched in ice-cold PBS and fixed in
4% (vol/vol) paraformaldehyde/PBS (pH 7.4) overnight at 4˚C. Fixed tissue samples were
washed with ice-cold PBS, embedded using Tissue-Tek O.C.T. Compound (Sakura Finetek),
frozen and stored at -80˚C. Five-micron cryosections were cut and mounted onto #1.5 cover-
slips. Tissue cryosections and fixed neonatal cardiomyocytes were permeabilized in 0.2% Tri-
ton X-100/PBS for 30 min. and blocked with 2% (wt/vol) BSA/1% normal donkey serum/PBS
for at least 1 hour at room temperature, and incubated in primary antibodies overnight at 4˚C.
They were thoroughly washed with PBS before being incubated in secondary antibodies (and
Phalloidin) for at least 2 hours at room temperature in the dark. After PBS washes, samples
were mounted onto slides using ProLong Diamond Antifade Mountant (Thermo Fisher
Scientific).
Fluorescent images were captured using DeltaVision RT System (GE Healthcare). Acquired
images were post-processed for deconvolution using SoftWoRx software (GE Healthcare).
Cardiac thin filament- and sarcomere lengths were measured using the DDecon plugin for
ImageJ [31,32]. Surface areas of neonatal cardiomyocytes stained with CellMask Orange
Plasma Membrane Stain (manufacturer’s protocol; Thermo Fisher Scientific) were measured
using ImageJ. Antibodies/fluorescent probes used included anti-leiomodin-2 (0.1–0.3 μg/mL)
(E13; Santa Cruz Biotechnology), anti-tropomodulin-1 (0.1μg/mL), anti-sarcomeric alpha-
actinin [1:1000] (EA-53; Sigma), Alexa Fluor Cascade Blue/405-conjugated goat-anti-mouse
or rabbit, [4 μg/mL] and Alexa Fluor 488/594/Cy5-conjugated goat-anti-mouse or rabbit
[2 μg/mL] antibodies. Alexa Fluor 488/594/Cy5-conjugated phalloidin [1:1000] (Invitrogen)
was used to stain F-actin.
Neonatal primary cardiomyocyte isolation and culture
Cardiomyocytes from mouse pups no older than post-natal day 3 (P3) were isolated and cul-
tured as described [33]. Briefly, neonatal hearts (from at least 3 animals per genotype per cul-
ture) were harvested from littermate Lmod2-TG and NTG mice. Pooled hearts were then
minced and digested 3x with collagenase and pancreatin for 10 min each in an incubator shak-
ing at 230 rpm at 37˚C. Isolated neonatal cardiomyocytes were plated in a 35-mm tissue cul-
ture dish containing Matrigel-coated #1.5 coverslips at ~450,000 cells per dish and were
cultured in DMEM (Gibco) with 10% (v/v) heat-inactivated FBS (HyClone) and 1% (vol/vol)
penicillin/streptomycin (Cellgro). Neonatal cardiomyocytes after 4-day post-plating were
fixed in 1% (wt/vol) paraformaldehyde in PBS for immunofluorescence staining (see above
section).
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Real-time quantitative PCR
Total-RNA from LV tissue samples were extracted using RNeasy Fibrous Tissue Mini Kit (Qia-
gen), and cDNA from 500 ng/μL total-RNA was synthesized using Maxima First Strand cDNA
Synthesis Kit (Thermo Fisher Scientific). Appropriate dilution of each cDNA sample was
mixed with an equal volume of Maxima SYBR Green qPCR master mix (Thermo Fisher Scien-
tific), and real-time qPCR was completed using Rotor-Gene Q cycler (Qiagen). Relative
changes in gene expression were quantified using 2^(-ΔΔCT) method as described [34].
Primer sequences were obtained from qPrimerDepot (NIH), and tested to ensure their ampli-
fication efficiencies were not significantly different than that of the control gene, ornithine
decarboxylase (ODC).
Transcriptome sequencing (RNA-Seq)
Total-RNA of P7 Lmod2-TG and NTG littermates (n = 4–6 from 2–3 litters) were extracted as
outlined in qPCR section and quantified using Bio-Analyzer (Agilent Technologies). Samples
with RNA integrity number (RIN) greater than 7.8 and the value of 28S/18S ratio greater than
1.8 were chosen for RNA-seq analysis (n = 3 each). The rest of the transcriptome sequencing
processes were completed by BGI Genomics.
Transmission electron microscopy (TEM)
Hearts of P7 and P30 (n = 3 each per genotype per time point) were dissected in 30 mmol/L
KCl (to arrest muscles in diastole), and LV tissues were further dissected into ~2x1 mm2 pieces
in a freshly-made fixative (pH 7.4; 2.5% glutaraldehyde, 2% paraformaldehyde, 0.1 mol/L
sodium cacodylate). Samples were fixed in a fresh change of fixative overnight at 4˚C. Fixed
samples were washed with 0.1 mol/L sodium cacodylate buffer (pH 7.4), and post-fixed/stained
with 1% Osmium tetroxide for 1 hour on ice. The samples were then washed with 0.1 mol/L
sodium acetate buffer (pH 5.2), and stained en-bloc with 2% uranyl acetate for 1 hour on ice.
Stained samples were then dehydrated in graded ethanol series and embedded using Spurr
Low Viscosity Embedding Kit (Sigma). Sixty-nanometer sections were cut and mounted onto
uncoated copper-mesh grids and stained sequentially with 2% uranyl acetate solution in etha-
nol and 2% lead acetate solution. TEM images were acquired on Tecnai G2 Spirit BioTWIN
microscope and processed using TEM Imaging and Analysis software (FEI). To account for
potential differences in sample shrinkage, sarcomere length and Z-disc width were divided by
A-band width for each sarcomere because the width of A-band (thick filament length) is con-
sistently at ~1.6 microns. Length of a perpendicular line across the two opposing membranes
of each adherens junctional structure was taken as the gap width of the adherens junctions.
Results
Transgenic mice with cardiac-specific Lmod2 overexpression
We generated a novel cardiac-specific transgenic mouse line stably expressing Myc-tagged
Lmod2 under control of the alpha-MHC (Myh6) promoter (S1A Fig). Heterozygous Lmod2
transgene-positive (Lmod2-TG) mice do not die prematurely and are able to breed when
Lmod2-TG males are crossed with Lmod2 transgene-null (NTG) females. However, the major-
ity of Lmod2-TG females do not survive through pregnancy, potentially due to volume-
induced cardiac stress (n = 10; percent fatality = 60%), and homozygous Lmod2 transgenic
pups do not survive past post-natal day 7 (n = 3 litters; percent fatality = 100%). Assembly of
Myc-Lmod2 at thin filament pointed ends in cardiomyocytes isolated from Lmod2 transgene-
positive hearts as indicated by immunofluorescence staining with anti-Myc antibodies (S1B
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Fig) is in agreement with the sub-cellular localization of endogenous Lmod2 protein [11]. We
studied morphological and functional consequences of cardiac-specific Lmod2 overexpression
at different developmental time points: right after birth (post-natal day one, P1), when cardio-
myocyte proliferation is considered complete (P7), following cardiac hypertrophy (P30), and
when the mice reach sexual maturity (P60). Lmod2 transgene-null (NTG) littermates served as
controls.
Lmod2 expression is significantly elevated in Lmod2-TG hearts
In order to measure the levels of Lmod2 protein expression, immunoblot analysis using total
protein extracted from the left ventricle (LV) of Lmod2-TG and NTG littermates at all four
developmental stages (see above) was performed. Lmod2 protein levels are elevated in
Lmod2-TG hearts as early as P1 (2 to 3-fold; P = 0.185) (Fig 1A), and to a greater degree at P7
(9 to 10-fold, P<0.0001), P30 (6 to 7-fold, P<0.0001) and P60 (5 to 6-fold; P = 0.003) (Fig 1A
and 1B). For both genotypes, no statistically significant differences in Lmod2 expression levels
are observed between male and female mice at all time points examined.
To determine the levels of total Lmod2 protein assembled into myofibrils in Lmod2-TG
hearts, soluble and insoluble (assembled) fractions of proteins at P7 (when the highest difference
in Lmod2 expression between NTG and Lmod2-TG was observed) were collected and analyzed
via immunoblot analysis (S2A Fig). A significant amount of Lmod2 is detected in the soluble
fraction of Lmod2-TG hearts, whereas endogenous Lmod2 is found only in the insoluble
(assembled) fraction in NTG hearts. Total Lmod2 levels are also significantly up in the insoluble
fraction of Lmod2-TG (S2A Fig; ~3.3-fold; n = 4 each; P<0.0001), indicating that much more
Lmod2 gets assembled in Lmod2-TG myofibrils, with about ~30% of exogenous Lmod2 being
incorporated. To examine whether there is any compensatory response to increased Lmod2
expression at the transcriptome-level, RNA-sequencing analyses of Lmod2-TG and NTG LV
samples were performed using P7 mice. No significant difference in mRNA-levels of Lmod1,
Lmod3, Tmod 1–3, as well as other thin filament proteins such as tropomyosin and troponins,
between Lmod2-TG and NTG cardiac transcriptomes is detected (S1 Table).
Lmod2-TG hearts have longer thin filaments as early as PD1
To determine if we did in fact manipulate (increase) the lengths of thin filaments in vivo, left
ventricular thin filament lengths were measured. Significantly longer cardiac thin filament
lengths were indeed observed in Lmod2-TG hearts at all time points measured: P1: ~3%,
P = 0.0005; P7: ~10%, P<0.0001; P30: ~7%, P<0.0001; P60: ~5%; P<0.0001 (Fig 1C and 1D;
n = 140–260 measurements from 4–8 animals per genotype). The greatest difference in thin fil-
ament lengths between Lmod2-TG and NTG hearts is observed at P7 (Fig 1D), when the rela-
tive expression level of Lmod2 is the highest in Lmod2-TG animals (Fig 1A and 1B) and before
the majority of phenotypic alterations are observed (see below). Remarkably, thin filament
lengths in Lmod2-TG hearts at P7 were observed to be as long as 1.10-micron; this is ~ 26%
longer than the average length observed in NTG hearts (0.87-micron; Figs 1C and S2B). To
our knowledge these are the longest cardiac thin filaments observed in mice.
Curiously, thin filaments of Lmod2-TG animals do not grow significantly longer after P7
(Fig 1C), while those of the NTG continue to increase in length; thereby reducing the length
difference between the two genotypes as the mice age. The fact that significantly longer cardiac
thin filaments are observed as early as P1 and in P7 Lmod2-TG mice when there is no signifi-
cant gross morphological (S2 Table) and functional (S3 Table) differences detected suggests
that this phenotypic manifestation is the primary effect following cardiac-specific Lmod2 over-
expression. Alpha-MHC promoter also drives an atrial tissue expression, especially before
Elongated thin filaments and heart failure
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birth; therefore, we also examined atrial thin filament lengths. Interestingly, thin filaments
from atrial fibers are also longer in Lmod2-TG mice, by ~5%, when compared with NTG (P15;
Lmod2-TG: 0.88 ± 0.007 μm; NTG: 0.84 ± 0.014 μm; (2M, 2F) each; P = 0.012, two-tailed
unpaired t-test). For both genotypes, no statistically significant differences in thin filament
lengths are observed between male and female mice at all time points examined.
Lmod2-TG hearts exhibit pathological hallmarks of cardiomyopathy
Although Lmod2-TG mice present with deformed hearts with enlarged atrial and ventricular
chambers, a phenotypic defect that is fully penetrant by P30 (Fig 2A and 2B), morphometric
Fig 1. High levels of Lmod2 protein expression in Lmod2-TG hearts correspond with longer thin filaments. (A)
Analysis of immunoblots of left ventricular (LV) tissue extracts of P1, P7, P30 and P60 mice probed with anti-Lmod2
antibodies. Lmod2 transgene expression is highly elevated in Lmod2-TG (black) when compared with endogenous
Lmod2 levels in NTG (white) at all time points. Data are presented as the relative expression level of Lmod2 in
Lmod2-TG animals when compared with NTG for each time point. (n = 4–8; Error bar = SEM; two-tailed unpaired t-
test). (B) Representative immunoblot (Lmod2 and c-Myc at ~80.kDa) and Ponceau S-stained membrane (PonS) of P7
LV extracts. (C) Quantitative measurements of cardiac thin filament length (TFL) in P1, P7, P30 and P60 mice. TFL of
Lmod2-TG hearts (black) are 3–10% longer when compared to those of NTG (white). Gray bars represent comparison
of NTG TFL between each time points, and black bars represent those of Lmod2-TG (n = 4–8; Error bar = SEM; two-
way ANOVA with Tukey test). (D) Representative fluorescently-conjugated phalloidin staining of LV tissue from P7
NTG and two Lmod2-TG (TG #1, #2) mice (arrows show thin filament pointed ends; Z shows Z-disc/thin filament
barbed ends). Scale bar = 1 μm.
https://doi.org/10.1371/journal.pone.0226138.g001
Fig 2. All chambers of Lmod2-TG hearts are enlarged with extensive interstitial fibrosis by post-natal day 30
(P30). (A) Atrial and ventricular chambers in Lmod2-TG hearts are larger than those in Lmod2 transgene-null (NTG)
hearts. Scale bar = 1 mm. (B) Trichrome histological stain indicates the existence of fibrosis within the ventricular
myocardium of Lmod2-TG hearts. (C) Quantification of Picrosirius Red-stained ventricular tissue reveals a
significantly higher level of interstitial fibrosis in Lmod2-TG (black), when compared with NTG (white) (n = 6–8;
Error bar = SEM; two-tailed unpaired Welch’s t-test).
https://doi.org/10.1371/journal.pone.0226138.g002
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analysis shows that heart weight-to-body weight (HW/BW), heart weight-to-tibia length
(HW/TL), lung weight-to-body weight (LW/BW) and lung weight-to-tibia length (LW/TL)
ratios of Lmod2-TG mice are only significantly greater than those of NTG littermate mice by
P60 (S2 Table; P<0.01). Increased HW/BW and HW/TL values in Lmod2-TG mice are a typi-
cal hallmark of cardiac hypertrophy, whereas increased LW/BW and LW/TL values suggest a
congested state of Lmod2-TG lungs.
While no significant morphometric differences are detected at P1 and P7, histological anal-
ysis reveals significantly increased levels of interstitial fibrosis within the ventricular walls of
Lmod2-TG hearts by P30 (Fig 2B and 2C; P<0.001), a pathological state that contributes to
ventricular stiffness, increased passive tension and decreased contractility. Reactivation of the
fetal gene program is a classic indicator of cardiac disease remodeling [35]; hence, expression
levels of five commonly measured fetal genes (Acta1, Myh6, Myh7, Nppa and Nppb; Table 1)
were examined via real-time quantitative PCR (qPCR) from LV tissue. Expression levels of
these genes are not significantly different in Lmod2-TG when compared to NTG at P7,
although 3 out of 5 (Acta1, Nppa and Nppb) are trending to be higher (Fig 3, top panels). The
expression levels of all fetal genes examined are significantly altered in Lmod2-TG hearts by
P30 (Fig 3, bottom panels; P<0.05).
To examine the consequences of Lmod2 overexpression at the ultrastructural level, LV tis-
sues of P7 and P30 Lmod2-TG and NTG littermates were subjected to transmission electron
microscopy (TEM). For each sample, sarcomere length and the widths of Z-discs and A-bands
were measured. Sarcomere length and Z-disc width measurements were normalized using the
corresponding A-band width to adjust for sample shrinkage during the TEM procedure. No
Table 1. Primers used in this study.
Primer Forward Sequence (50 - 30) Reverse Complement (50 - 30) Expected Size (bp)
Acta1 CTCTCCTCAGGACGACAATC TTTTCCATTTCCTTTCCACA 177
Myh6 GCGCATTGAGTTCAAGAAGA CTTCATCCATGGCCAATTCT 103
Myh7 GTGGCTCCGAGAAAGGAAG GAGCCTTGGATTCTCAAACG 98
Nppa GGGGGTAGGATTGACAGGAT AGGGCTTAGGATCTTTTGCG 130
Nppb ACAAGATAGACCGGATCGGA ACCCAGGCAGAGTCAGAAAC 110
ODC ACATCCAAAGGCAAAGTTGG AGCCTGCTGGTTTTGAGTGT 102
https://doi.org/10.1371/journal.pone.0226138.t001
Fig 3. Real-time quantitative PCR (qPCR) of fetal genes in NTG and Lmod2-TG shows significant disease
progression at P30. Re-activation of the fetal gene program is indicative of a diseased state of the heart; hence, qPCR
of Lmod2-TG mice at P7 (top panels) and P30 (bottom panels) were examined using mRNA extracted from LV tissue.
Though not statistically significant, relative expression levels of 3 out of 5 molecular heart disease markers (Acta1,
Nppa and Nppb) are trending higher in Lmod2-TG (black) when compared to NTG (white) at P7. At P30, relative
expression levels of all disease markers examined are significantly altered (n = 4–6; Error bar = SEM; two-tailed
unpaired Welch’s t-test).
https://doi.org/10.1371/journal.pone.0226138.g003
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statistically significant differences between the normalized sarcomere lengths of Lmod2-TG
and NTG were observed at both P7 and P30 (S3B Fig; n = 3 each). However, Lmod2-TG hearts
have significantly wider Z-discs when compared to NTG littermates at both P7 and P30 (S3C
Fig; P7: ~20%, P = 0.0001; P30: ~28%, P = 0.0008). Furthermore, myofibrillar organization in
Lmod2-TG heart is in complete disarray by P30 (Fig 4).
Myofibrillar disarray is often followed by dissolution of intercalated discs (ICD) [36], the
junctional structures that allow transmission of electromechanical impulses between adjacent
cardiac myocytes. By P30 varying degrees of perturbation of the ICDs is observed in
Lmod2-TG (S3A Fig, chevrons). In particular, the gap width, a measure of the perpendicular
distance between the two opposing membranes of adherens junctions, is significantly wider in
Lmod2-TG hearts as early as P7 (P7: ~64%, P = 0.0002; P30: ~45%, P = 0.0015) (S3D Fig). Fur-
thermore, the expression level of N-cadherin (a major adherens junction protein) is signifi-
cantly upregulated in Lmod2-TG hearts (P7: ~1.4-fold; P30: ~2.7-fold; (2M, 2F) each; P<0.05).
Altered N-cadherin expression in the myocardium has been shown to cause cardiomyopathies
due to disruption of contractile dynamics by excess cadherin/catenin complexes [37–40].
Although ruptured ICDs is one prominent pathological manifestation present in cardiomyop-
athy [41], the abnormalities in ICDs and elevated N-cadherin expression level were first
observed at P7 in Lmod2-TG, when other indicators of disease remodeling, such as gross mor-
phology and reactivation of the fetal gene program, are yet to be significantly represented. As
such, Lmod2 may have a functional role in ICD structures, independent of disease
progression.
Left ventricular Lmod2-TG fibers produce significantly less active
contractile force
To investigate the mechanical consequences of longer cardiac thin filaments, the contractile
properties of single unbranched trabecular fibers extracted from the left ventricular outer wall
were measured. We chose to study the P60 mice first because this is the youngest age after the
myosin isoform switch (from fetal Myh6 to adult Myh7) has occurred. At P60 maximally acti-
vated force in Lmod2-TG was reduced by ~50% compared to NTG littermates, at both sarco-
mere lengths observed (1.95 and 2.10 microns; Fig 5A and 5B and S4 Table), along with
reduction in cooperativity of myofilament proteins (Hill Coefficient, S4 Table). Calcium sensi-
tivity (EC50, S4 Table) was not significantly different between NTG and Lmod2-TG at
Fig 4. Ultrastructural analysis of Lmod2-TG heart indicates extensively disrupted myofibrillar organization.
Transmission electron micrograph of P30 LV tissue reveals disorganized myofibrillar cytoarchitecture, with out-of-
register sarcomeres in Lmod2-TG hearts (representative images from n = 3 per genotype; scale bar = 2 μm).
https://doi.org/10.1371/journal.pone.0226138.g004
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1.95-micron; however, when fibers were stretched to a length of 2.10 microns the calcium sen-
sitivity in Lmod2-TG fibers was reduced (desensitized) compared to NTG fibers.
Next, to rule out potential interference from disease progression that we believe to have
already taken place in P60 Lmod2-TG mice, we analyzed mice at P15, the youngest mice we
were able to get accurate measurements from. No significant differences in average passive
tension, calcium sensitivity and myofilament cooperativity were observed between Lmod2-TG
and NTG (Fig 5C, and S4 Table). However, active mechanical force produced in Lmod2-TG
mice was significantly reduced, by ~47%, when compared to NTG mice. These P15 single-
fiber mechanics data suggests that the primary factor contributing to reduced cardiac contrac-
tile force observed in Lmod2-TG mice is the limited interaction between thin and thick
filaments.
Progressive loss of ventricular contractility can deplete circulatory reserve [42], therefore,
maximal cardiac reserve available in Lmod2-TG mice was determined via LV M-mode echo-
cardiography before and after beta-agonist treatment [43]. Dobutamine, an inotropic stimu-
lant that targets beta1-receptors, the most common beta-adrenergic receptor type in cardiac
tissue, was used in this experiment. Echocardiography data before and after dobutamine treat-
ment (1.5 mg/kg for 5 min) of P30 Lmod2-TG and NTG littermates were analyzed. Except for
an increased heart rate (~27% increase from 352 ± 13 to 448 ± 29 beats/min; (2M, 2F) each;
P<0.05), Lmod2-TG hearts show a blunted response to dobutamine treatment, i.e., little to no
significant functional improvements upon stimulation, when compared to NTG hearts that
shows significant improvements in almost all criteria measured (heart rate, percent ejection
fraction and percent fractional shortening shown in S5 Table; P<0.05). These data suggest that
Lmod2-TG mice lack a cardiac reserve and any significant stress on their hearts may be fatal;
this may explain the fatality observed during pregnancy of Lmod2-TG females.
Lmod2-TG mice suffer from both systolic and diastolic dysfunction
To further decipher functional defects in Lmod2-TG hearts, we conducted pressure-volume
loop (PV-Loop) analysis; this approach provides comprehensive load-independent measure-
ments of ventricular systolic and diastolic function [44,45]. To maximize the reliability of the
data acquired only P60 mice were utilized for this study. PV-Loop analysis of Lmod2-TG
hearts indicates loss of inotropy [decreased slope in end-systolic pressure-volume relationship
(ESPVR)] and loss of compliance [increased slope in end-diastolic pressure-volume
Fig 5. Overexpression of Lmod2 negatively affects contractile force at the single myofiber level. At P15, Lmod2-TG
trabeculae fibers (black) show a significant drop in raw force measured at sarcomere lengths of 1.95 μm (A) and
2.10 μm (B) when compared with NTG fibers (gray), indicative of defective contractile force generation. Passive
tension average (C), as well as the calcium sensitivity (EC50) and myofilament cooperativity (Hill coefficient) (S4
Table) of P15 Lmod2-TG and NTG littermates are not significantly different from each other. By P60, however, passive
tension average (C) in Lmod2-TG (red) is drastically higher than those of NTG (blue), most likely due to extensive
interstitial fibrosis. N = 1 fiber per animal from 7–9 animals. Error Bar = SEM.
https://doi.org/10.1371/journal.pone.0226138.g005
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relationship (EDPVR)], indicating decreased contractility and increased stiffness in
Lmod2-TG hearts (Fig 6C and S6 Table). Further, Lmod2-TG hearts present with lower peak
systolic pressure with higher end-diastolic pressure, and higher relaxation constant (Tau) val-
ues, explaining the inadequate systolic ejection and insufficient diastolic relaxation functions
(S6 Table). Significantly less contractile force generated in Lmod2-TG left ventricles (Fig 5A
and 5B and S4 Table) is likely the major factor resulting in systolic dysfunction (i.e., primary
defect) and ventricular wall stiffness, due to hypertrophy with extensive interstitial fibrosis, is
likely the major contributing factor of diastolic dysfunction (i.e., secondary defect).
Functional defects following cardiac-specific overexpression of Lmod2 are
successfully prevented by turning the transgene expression off
To verify that excess Lmod2 is the primary cause of cardiac dysfunction in Lmod2-TG mice,
Lmod2 transgene expression was silenced by introducing Cre-recombinase (S1A Fig) via
adeno-associated viral (AAV) transduction at P3. Strikingly, gross morphological defects, such
as dilated cardiac chambers, are no longer apparent in Cre-injected Lmod2-TG mice
(Lmod2-cre) ([5M, 5F], 100% absence of gross morphology compared with Lmod2-TG by
P60). The levels of Lmod2 protein expressed in Lmod2-cre are comparable to NTG-level,
while being significantly lower (~5-fold) than Lmod2-TG (Fig 6A; P<0.0001). Similarly, thin
filament lengths in Lmod2-cre hearts are not significantly different from those of NTG, while
being significantly shorter by ~5% than Lmod2-TG (Fig 6B; P<0.0001). Furthermore, cardiac
functional defects observed in Lmod2-TG mice, such as systolic and diastolic performance
were rescued in Lmod2-cre mice as indicated by PV-Loop analysis (Fig 6C and S6 Table).
Using only one-tenth of the virus concentration (Cre_1X), which was used above to achieve
~100% prevention of disease onset as shown in Fig 6, resulted in incomplete silencing of
Lmod2 transgene expression and incomplete prevention of accompanying aberrant pheno-
types (such as elongation of thin filament length and reduced percent ejection fraction; S4 Fig).
Therefore, it can be concluded that excess Lmod2 protein is the primary cause that triggers
thin filament elongation and cardiac dysfunction in Lmod2-TG animals.
Discussion
Our laboratory has recently discovered a direct link between leiomodin-2 and human cardio-
myopathy based on a case study of an infant with a homozygous Lmod2 nonsense mutation
Fig 6. Lmod2 transgene expression off: Lmod2 contributes to in vivo cardiac function. (A) Analysis of
immunoblots of P60 LV tissue extracts probed with anti-Lmod2 antibodies. Lmod2-cre mice, Lmod2-TG with Lmod2
transgene expression turned off, have Lmod2 protein levels similar to NTG. (B) Lmod2-cre mice have thin filament
lengths similar to those of NTG. (C) Pressure-Volume Loops analysis reveals that the systolic (ESPVR, end-systolic
pressure-volume relationship) and diastolic (EDPVR, end-diastolic pressure-volume relationship) dysfunctions
observed in Lmod2-TG mice can be prevented by turning Lmod2 transgene expression off. N = 4–6; Error bar = SEM;
non-parametric one-way ANOVA with Tukey test.
https://doi.org/10.1371/journal.pone.0226138.g006
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[19]. Strikingly, the clinical phenotypes observed in the patient are similar, if not identical, to
the phenotypic defects observed in constitutive Lmod2-KO mice; in particular, extremely short
thin filaments and the observation that Lmod2 is required for post-natal survival [4,19]. In this
study, we generated a novel transgenic mouse model capable of stably overexpressing Lmod2
in cardiac tissues in a reversible manner (Lmod2-TG) to study the consequences of longer thin
filaments, in the context of an intact heart.
Our data demonstrate that the maintenance of thin filament lengths is indeed critical for
heart muscle function. More importantly, we show for the first time that mammalian intact
hearts with longer thin filaments in vivo result in a complex cardiomyopathy; whereas, we pre-
viously demonstrated that shorter thin filaments in vivo result in rapid onset dilated cardiomy-
opathy. At all major postnatal developmental time points examined Lmod2 protein expression
levels were elevated in Lmod2-TG mice, with the highest relative expression level difference of
9–10 fold observed at P7 (end of cardiac hyperplasia). Similarly, cardiac thin filaments were
significantly longer at all stages in Lmod2-TG hearts with the largest difference in lengths
observed at P7 (~10% on average with some filaments observed to be up to ~26% longer).
Interestingly, although the relative expression levels of Lmod2 are significantly elevated in
Lmod2-TG at all time point examined, cardiac thin filaments in Lmod2-TG hearts do not
grow significantly longer beyond P7 (average of 0.96 μm, and maximum of 1.10 μm). Mean-
while, thin filaments in NTG significantly lengthen until P60 (average of 0.92 μm, and maxi-
mum of 1.06 μm). Therefore, it can be concluded that: (1) the apparent physiological limit of
mouse cardiac thin filament length is ~1.10 μm; and (2) at constant sarcomere lengths, thin fil-
aments in Lmod2-TG overlap within individual sarcomeres, likely preventing the optimum
interaction between thin (actin) and thick (myosin) filaments.
Most, if not all, of our data suggest that the primary effect of excess Lmod2 is elongated thin
filaments, and that this alteration leads to cardiac disease progression. In support of this, we
observe elongated thin filaments as early as P1, before any other morphological and functional
alterations that we could measure were observed, such as morphology (S5 FigB and S2 Table),
level of interstitial fibrosis (S5A Fig and S1 Table), fetal gene expressions (Fig 3) and echocardi-
ography (LV M-mode; S3 Table). Further, the greatest difference in thin filament lengths
between Lmod2-TG and NTG hearts is observed at P7, when the relative expression level of
Lmod2 is the highest in Lmod2-TG animals, and again before the majority of phenotypic and
functional alterations are observed.
The data from our single-fiber mechanics study, especially of those acquired at P15, are
consistent with the idea that the primary factor contributing to reduced cardiac contractile
force observed in Lmod2-TG mice is the limited interaction between thin and thick filaments.
In fact, Lmod2-TG mice at P15 have 7–8 fold higher Lmod2 expression and ~8% longer thin
filaments that produce ~47% less active contractile force. This 8% increase in thin filament
length in hearts of Lmod2-TG is predicted to result in a rightward shift in the sarcomere
length-tension relationship, and consequently, a 10–20% reduction in maximum tension at
sarcomere lengths on the ascending limb of the relationship; the reduction predicted to be due
to interference of overlapping thin filaments [29,46–48]. Therefore, the ~47% reduction in
maximum force observed in Lmod2-TG animals at both sarcomere length measured cannot
be solely explained by an increase in thin filament lengths because the longer sarcomere length
tested (2.10-micron) is outside the double overlap suggested by an 8% increase in thin filament
lengths. As such, some other mechanism, in addition to elongated thin filaments, must be con-
tributing to the reduction in production and/or transmission of contractile force within the
isolated single fibers.
We hereby propose two additional ways that excess Lmod2 can contribute to impaired pro-
duction of contractile force. First, excess soluble Lmod2 may bind to the sides of actin (thin)
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filaments and effectively limit the interaction of thin and thick filaments. This idea is based on
reports that excess Lmod2 in isolated cardiomyocytes can assemble along the length of the thin
filaments and interfere with proper myosin cross-bridge formation leading to a decrease in
force production [11,49]. Second, our TEM data show that Lmod2-TG hearts have disorga-
nized myofibrils, wider Z-discs and ruptured intercalated discs. We thus propose that longer
thin filaments in Lmod2-TG heart leads to myofibrillar disarray that reduces sarcomeric ten-
sion, which in turn disrupts assembly and maintenance of intercalated disc (ICD) structures.
Because ICD structures between adjacent cardiomyocytes ensure efficient propagation of elec-
tromechanical impulses, disrupted ICDs observed in Lmod2-TG hearts would be predicted to
interfere with mechanical force transmission from one cardiomyocyte to another, contributing
to the total contractile force deficit.
When Lmod2 transgene expression is turned off in Lmod2-TG mice via adeno-associated
viral transduction of Cre-recombinase, all detectable phenotypical and functional aberrations
observed in Lmod2-TG mice, such as longer thin filament length, enlarged cardiac chambers,
and systolic and diastolic dysfunction are successfully prevented. We observed that the degree
of phenotypical and functional defects prevented in Lmod2-cre hearts are dependent on the
amount of Cre-recombinase injected into Lmod2-TG pups. These data suggest that cardiac-
specific overexpression of Lmod2 with subsequent thin filament elongation is the primary
causative factor leading to eventual heart failure in Lmod2-TG mice.
To our knowledge, Lmod2 is the only protein shown to have a direct correlation between
the amount of expressed protein, thin filament length and cardiac function in vivo. Specifically,
the absence of Lmod2 in cardiac-specific Lmod2-KO mice results in shorter thin filaments
with the lengths linked to the amount of knockdown via tamoxifen dose [50], while here we
show that increasing the levels of Lmod2 expressed in cardiac muscle is positively correlated
with increased thin filament lengths. Although this result is what we predicted from assays in
cell culture, it is remarkable that we can manipulate thin filaments lengths so precisely in intact
hearts because of the presence of known and presumably unknown regulatory mechanisms.
We conclude that Lmod2 dictates in vivo cardiac function by its contribution to sarcomeric
integrity and actin-myosin interactions via regulation of thin filament length, and that the
Lmod2-TG model serves as the model where we can learn how repeated cellular-level insults
(functional performance of elongated thin filaments at each contraction-relaxation cycle)
progress into heart failure.
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